0001179110-20-004530.txt : 20200402
0001179110-20-004530.hdr.sgml : 20200402
20200402171747
ACCESSION NUMBER: 0001179110-20-004530
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200331
FILED AS OF DATE: 20200402
DATE AS OF CHANGE: 20200402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOTT DARCY G
CENTRAL INDEX KEY: 0001179972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36568
FILM NUMBER: 20770190
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHEQUITY, INC.
CENTRAL INDEX KEY: 0001428336
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
BUSINESS PHONE: 801-727-1000
MAIL ADDRESS:
STREET 1: 15 WEST SCENIC POINTE DRIVE
STREET 2: SUITE 100
CITY: DRAPER
STATE: UT
ZIP: 84020
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHEQUITY INC
DATE OF NAME CHANGE: 20080227
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-31
0
0001428336
HEALTHEQUITY, INC.
HQY
0001179972
MOTT DARCY G
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
DRAPER
UT
84020
0
1
0
0
Executive VP and CFO
Common Stock
2020-03-31
4
A
0
7921
0
A
37921
D
Common Stock
2020-03-31
4
A
0
3623
0
A
41544
D
Common Stock
2020-03-31
4
A
0
19073
0
A
60617
D
Common Stock
2020-03-31
4
A
0
8236
0
A
68853
D
Stock Option (right to buy)
41.28
2027-03-27
Common Stock
19897
19897
D
Stock Option (right to buy)
25.39
2025-03-26
Common Stock
25000
25000
D
Stock Option (right to buy)
14
2024-07-30
Common Stock
100000
100000
D
Stock Option (right to buy)
61.72
2028-03-27
Common Stock
14228
14228
D
Stock Option (right to buy)
73.61
2029-03-26
Common Stock
15337
15337
D
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 7,921 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 3,623 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 19,073 shares on March 31, 2020.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in four equal installments of 2,059 shares on each of March 31, 2021, 2022, 2023, and 2024.
The option is exercisable as to 14,922 shares. The option vests as to 4,975 shares on March 27, 2021.
The option is immediately exercisable.
The option is exercisable as to 7,114 shares. The remaining options vest in two equal installments of 3,557 shares on March 27, 2021, and 2022.
The option is exercisable as to 3,835 shares. The remaining options vest as to 3,834 shares on each of March 27, 2021, 2022 and 2023.
/s/ Darcy G. Mott
2020-04-02